Transcellular Formation of Thromboxane A2 in Mixed Incubations of Endothelial Cells and Aspirin-Treated Platelets Strongly Depends on the Prostaglandin I-Synthase Activity
- 1 July 2000
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 99 (2) , 155-164
- https://doi.org/10.1016/s0049-3848(00)00241-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Rate of Vasoconstrictor Prostanoids Released by Endothelial Cells Depends on Cyclooxygenase-2 Expression and Prostaglandin I Synthase ActivityCirculation Research, 1998
- Differential Suppression of Thromboxane Biosynthesis by Indobufen and Aspirin in Patients With Unstable AnginaCirculation, 1997
- Cyclooxygenases-1 and −2 of Endothelial Cells Utilize Exogenous or Endogenous Arachidonic Acid for Transcellular Production of ThromboxaneJournal of Biological Chemistry, 1996
- Thromboxane A2/prostaglandin H2-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase.Published by Elsevier ,1994
- Cyclooxygenase Gene Expression in Inflammation and AngiogenesisaAnnals of the New York Academy of Sciences, 1993
- Human cyclooxygenase-2 cDNA.Proceedings of the National Academy of Sciences, 1992
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart DiseaseNew England Journal of Medicine, 1981
- Coronary Arterial Smooth Muscle Contraction by a Substance Released from Platelets: Evidence That It Is Thromboxane A 2Science, 1976
- Acetylation of prostaglandin synthase by aspirin.Proceedings of the National Academy of Sciences, 1975